CTRI/2023/02/049696已完成2 期
A Clinical Study to Evaluate the Efficacy and Safety of Polyherbal Unani Formulations in the Management of Qul ? (Aphthous stomatitis)
State Unani Medical College, himmatganj Prayagraj0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients of any sex in the age group of 18-65 years
- •2.Presence of single/multiple ulcers in the oral cavity or tongue with the presence of any of the following symptoms
- •Difficulty in any eating/chewing/speaking/swallowing or burning sensation, pain in the oral cavity,coated tongue, excessive salivation
- •3.Patients clinically diagnosed with Qul ? (Aphthous stomatitis)
排除标准
- •The following patients will be excluded
- •1.Pregnant and lactating mothers.
- •2.Patient with severe renal, hepatic, and cardiac disease.
- •3.Those who have a history of systematic underlying disease (Crohn’s disease, Ulcerative Colitis, Behcet’s syndrome, Sweet’s Syndrome, Lupus erythematosus) and Diabetes mellitus.
- •4.Those diagnosed with oral cavity carcinoma.
- •5. Patient of hypertension.
- •6.Patient unsure about attending treatment schedule regularly.
研究者
相似试验
尚未招募
2 期
Treatment of ithy, red, dry and cracked skin condition (Eczema) by of Unani drugCTRI/2017/12/010957Central Research Institute of Unani Medicine
已完成
2 期
A Clinical Study to Evaluate the Efficacy and Safety of JR-031 in Patients with Epidermolysis BullosaEpidermolysis BullosaJPRN-UMIN000026645Osaka University6
招募中
不适用
Evaluation of the usefulness and safety of the combined use of an ear prosthesis and a cartilage conduction hearing aidJPRN-UMIN000044711Keio University30
尚未招募
2 期
Effectiveness of Unani Drugs in High Blood PressureCTRI/2017/12/011006Central Research Institute of Unani Medicine
进行中(未招募)
不适用
Study Evaluating Rapamune® Maintenance RegimeRenal transplantationMedDRA version: 17.1Level: PTClassification code 10038533Term: Renal transplantSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2014-004101-33-Outside-EU/EEAWyeth Korea, Inc.79
